ALLENA PHARMACEUTICALS INC (ALNA) Stock Analyst Earnings Estimates
NASDAQ:ALNA - Nasdaq - US0181191075 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | ||||||||
| EBITDA YoY % growth | -13.81M | -24.14M -74.80% | -20.88M 13.50% | -35.51M -70.07% | -46.76M -31.68% | -31.82M 31.95% | -47.286M -48.60% | N/A 35.52% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.91M | -24.19M -73.90% | -20.95M 13.39% | -35.59M -69.88% | -46.92M -31.83% | -31.99M 31.82% | -47.649M -48.95% | N/A 9.53% | N/A -26.76% | N/A 54.15% | N/A -11.47% | N/A -13.70% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.72 47.14% | -2.13 -23.84% | -1.03 51.64% | -0.73 29.13% | N/A 56.68% | N/A 1.61% | N/A 83.61% | N/A -39.81% | N/A -42.61% |
All data in USD
| Q3 / 22 | Q4 / 22 | |
|---|---|---|
| EPS Q2Q % growth | -0.07 58.00% | -0.07 39.73% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -5.761M 53.66% | -5.422M 46.43% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -0.08 66.67% | -0.08 | 0.00 | -4.58% |
| Q1 2022 Q2Q % growth | -0.13 38.10% | -0.15 | 0.02 | 12.10% |
| Q4 2021 Q2Q % growth | -0.11 54.17% | -0.17 | 0.06 | 34.64% |
| Q3 2021 Q2Q % growth | -0.17 22.73% | -0.19 | 0.02 | 9.91% |
| Q2 2021 Q2Q % growth | -0.24 7.69% | -0.21 | -0.03 | -12.04% |
| Q1 2021 Q2Q % growth | -0.21 32.26% | -0.23 | 0.02 | 9.50% |
| Q4 2020 Q2Q % growth | -0.24 48.94% | -0.20 | -0.04 | -21.91% |
| Q3 2020 Q2Q % growth | -0.22 61.40% | -0.22 | 0.00 | -1.33% |
| Q2 2020 Q2Q % growth | -0.26 51.85% | -0.31 | 0.05 | 14.87% |
| Q1 2020 Q2Q % growth | -0.31 43.64% | -0.46 | 0.15 | 32.46% |
| Q4 2019 Q2Q % growth | -0.47 | -0.54 | 0.07 | 13.37% |
| Q3 2019 Q2Q % growth | -0.57 | -0.50 | -0.07 | -13.67% |
| Q2 2019 Q2Q % growth | -0.54 | -0.55 | 0.01 | 1.41% |
| Q1 2019 Q2Q % growth | -0.55 | -0.50 | -0.05 | -10.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |